tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IMTX Stock Latest News

Immatics: Promising Pipeline and Financial Stability Drive Buy Rating
RatingsImmatics: Promising Pipeline and Financial Stability Drive Buy Rating
9d ago
IMTX
Immatics Reports Increased Q1 2025 Loss Amid Rising R&D Costs
PremiumCompany Announcements
Immatics Reports Increased Q1 2025 Loss Amid Rising R&D Costs
11d ago
6K
IMTX
Immatics reports Q1 EPS (EUR 0.33) vs (EUR 0.03) last year
PremiumThe Fly
Immatics reports Q1 EPS (EUR 0.33) vs (EUR 0.03) last year
11d ago
IMTX
Immatics: Strong Buy Rating Backed by Pipeline Progress and Financial Stability
PremiumRatings
Immatics: Strong Buy Rating Backed by Pipeline Progress and Financial Stability
2M ago
IMTX
Immatics Reports Strong 2024 Financial Results and Progress
PremiumCompany Announcements
Immatics Reports Strong 2024 Financial Results and Progress
2M ago
IMTX
Immatics files $500M mixed securities shelf
PremiumThe FlyImmatics files $500M mixed securities shelf
2M ago
IMTX
Immatics Advances Cancer Immunotherapy with Phase 3 Trial and Strong Financials
Premium
Company Announcements
Immatics Advances Cancer Immunotherapy with Phase 3 Trial and Strong Financials
2M ago
6K
IMTX
Immatics reports FY24 EPS EUR 0.14 vs (EUR 1.18) last year
Premium
The Fly
Immatics reports FY24 EPS EUR 0.14 vs (EUR 1.18) last year
2M ago
IMTX
Immatics Advances PRAME Cell Therapy and Expands Oncology Pipeline
PremiumCompany Announcements
Immatics Advances PRAME Cell Therapy and Expands Oncology Pipeline
4M ago
6K
IMTX
Immatics price target lowered to $13 from $15 at BofA
PremiumThe Fly
Immatics price target lowered to $13 from $15 at BofA
5M ago
IMTX
Immatics Faces Termination of Key Collaboration with Bristol Myers Squibb
PremiumCompany Announcements
Immatics Faces Termination of Key Collaboration with Bristol Myers Squibb
5M ago
6K
IMTX
Immatics N.V. Reports Strong Q3 2024 Progress and Financials
PremiumCompany Announcements
Immatics N.V. Reports Strong Q3 2024 Progress and Financials
6M ago
IMTX
Immatics moved to Buy from Not Rated at Goldman Sachs
PremiumThe FlyImmatics moved to Buy from Not Rated at Goldman Sachs
6M ago
IMTX
Immatics price target lowered to $15 from $16 at BofA
Premium
The Fly
Immatics price target lowered to $15 from $16 at BofA
6M ago
IMTX
Immatics price target lowered to $18 from $19 at Leerink
Premium
The Fly
Immatics price target lowered to $18 from $19 at Leerink
6M ago
IMTX
Immatics announces clinical data on TCER IMA402 targeting PRAME
PremiumThe Fly
Immatics announces clinical data on TCER IMA402 targeting PRAME
6M ago
IMTX
Immatics Sees Revenue Surge Despite R&D Expenses
PremiumCompany Announcements
Immatics Sees Revenue Surge Despite R&D Expenses
6M ago
6K
IMTX
Immatics sees cash runway into 2H27
PremiumThe Fly
Immatics sees cash runway into 2H27
6M ago
IMTX
Immatics reports Q3 EPS (EUR 0.11) vs. (EUR 0.32) last year
PremiumThe Fly
Immatics reports Q3 EPS (EUR 0.11) vs. (EUR 0.32) last year
6M ago
IMTX
IMTX Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsIMTX Upcoming Earnings Report: What to Expect?
6M ago
IMTX
Immatics Unveils Promising TCR-T Therapy Developments
Premium
Company Announcements
Immatics Unveils Promising TCR-T Therapy Developments
7M ago
6K
IMTX
Immatics N.V. Announces Major Share Offering
Premium
Company Announcements
Immatics N.V. Announces Major Share Offering
7M ago
6K
IMTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >